SEC Comment Letter for cbdMD, Inc. (YCBD) (CIK 0001644903) (YCBD) — Mar 1, 2019
cbdMD, Inc. (YCBD) (CIK 0001644903)
Date: March 1, 2019 · CIK: 0001644903 · Accession: 0000000000-19-003577
AI Filing Summary & Sentiment
File numbers found in text: 001-38299
Show Raw Text
February 28, 2019
Mark S. Elliott
Chief Financial Officer and Chief Operating Officer
Level Brands, Inc.
4521 Sharon Road, Suite 450
Charlotte, NC 28211
Re:Level Brands, Inc.
Preliminary Information Statement on Schedule 14A
Filed February 14, 2019
File No. 001-38299
Dear Mr. Elliott:
We have reviewed your filing and have the following comments. In some of our
comments, we may ask you to provide us with information so we may better understand your
disclosure.
Please respond to these comments within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe our
comments apply to your facts and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have additional comments.
Preliminary Proxy Statement on Schedule 14A filed February 14, 2019
General
1.We note that you are seeking shareholder approval for the issuance of stock that will serve
as consideration under the Merger Agreement with Cure Based Development,
LLC. Please provide the disclosure required by Item 13 of Schedule 14A. Refer to Note
A of Schedule 14A.
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
FirstName LastNameMark S. Elliott
Comapany NameLevel Brands, Inc.
February 28, 2019 Page 2
FirstName LastName
Mark S. Elliott
Level Brands, Inc.
February 28, 2019
Page 2
Please contact Sergio Chinos, Staff Attorney, at (202) 551-7844 or Jay Ingram, Legal
Branch Chief, at (202) 551-3397 with any questions.
Sincerely,
Division of Corporation Finance
Office of Manufacturing and
Construction
cc: Brian Pearlman